A photo of Anne Lucky.

Anne W. Lucky, MD


  • Medical Director, Epidermolysis Bullosa Center
  • Volunteer Professor of Dermatology and Pediatrics, UC Department of Pediatrics
  • Board Certified
I believe each patient and family deserves my full attention. It’s vital to listen to patients and know them as people, not just to understand their medical issues.
Anne W. Lucky, MD

About

Biography

As a pediatric dermatologist, I have a special interest in epidermolysis bullosa (EB), and I also care for patients with other genetic disorders and those with difficult acne.

I wanted to be a pediatrician for as long as I can remember. Before I became a pediatric dermatologist, I practiced in general pediatrics, genetics and pediatric endocrinology. I was drawn to caring for children with EB because they are underserved, and many of their needs are complex.

At Cincinnati Children’s interdisciplinary Epidermolysis Bullosa Center, our team offers comprehensive care for all aspects of EB. We are happy to work with patients and their families to give them the best possible diagnoses and treatments.

My background allows me to evaluate and care for the whole patient with the help from my colleagues at Cincinnati Children’s. I believe each patient and family deserves my full attention. It’s vital to listen to patients and know them as people, not just to understand their medical issues. I also know the limits of my knowledge and consult with my colleagues in other specialties.

I have been honored to receive several awards for my clinical practice and service over the years. These recognitions have come from national societies such as the American Academy of Pediatrics, the Society for Pediatric Dermatology and the Dermatology Foundation.

In my research, my colleagues and I are doing clinical trials of new medications for EB and looking into gene therapy to help with wound healing.

In my spare time, my husband and I love to hike and travel. Visiting with my grandchildren is one of my greatest pleasures.

BA: Pembroke College in Brown University, Providence, RI, 1966.

MD: Yale University School of Medicine, New Haven, CT, 1970.

Residency: Children's Hospital Medical Center, Boston, MA, 1973; Yale University School of Medicine, New Haven, CT, 1981.

Fellowship: Human Genetics and Pediatrics, Yale University School of Medicine, New Haven, CT, 1974; Clinical Associate (Endocrinology), Reproduction Research Branch of the National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Md., 1976.

Certification: Pediatrics, 1975; Pediatric Endocrinology, 1978; Dermatology, 1981.

Interests

All aspects of pediatric dermatology, especially acne

Services and Specialties

Dermatology, Epidermolysis Bullosa EB

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa. Paller, AS; Guide, SV; Ayala, D; Gonzalez, ME; Lucky, AW; Bagci, IS; Marinkovich, MP. Journal of Dermatological Treatment. 2024; 35:2350232.

Topical everolimus therapy for epidermal nevi associated with woolly hair nevus in a patient with a mosaic HRAS mutation. Singh, A; Gorell, ES; Lucky, AW. Pediatric Dermatology. 2024; 41:871-873.

Inpatient management of epidermolysis bullosa: Consensus-based hands-on instructions for neonates and postneonates. Abreu Molnar, B; Levin, L; Yun, D; Morel, K; Wiss, K; Wieser, J; Ward, C; Trice, H; Garcia-Romero, MT; Stephenson, A; Boulrice, B; Bayliss, S; Badger, K; Paller, AS. Journal of the American Academy of Dermatology. 2024; 91:290-299.

To prevent pain and anxiety, culture samples may be obtained from wound dressings. Iqneibi, M; Gorell, ES; Lucky, AW. Pediatric Dermatology. 2024; 41:563-564.

Characterization of wound microbes in epidermolysis bullosa: A focus on Pseudomonas aeruginosa. Scollan, ME; Levin, LE; Lucky, AW; Hook, KP; Peoples, K; Bruckner, AL; Feinstein, JA; Pope, E; McCuaig, CC; Powell, J; Glick, SA; Paller, AS; Browning, JC; Morel, KD. Pediatric Dermatology. 2023; 40:863-865.

Assessing pain catastrophizing and functional disability in pediatric epidermolysis bullosa patients. Rangu, S; Collins, J; García-Romero, MT; Augsburger, BD; Bruckner, AL; Diaz, LZ; Eichenfield, LF; Faig, W; Gorell, ES; Lefferdink, R; Peoples, K; Wiss, K; Perman, MJ; Castelo-Soccio, L. Pediatric Dermatology. 2023; 40:422-427.

Iron status and burden of anemia in children with recessive dystrophic epidermolysis bullosa. Tarango, C; Quinn, CT; Augsburger, B; Lucky, AW. Pediatric Dermatology. 2023; 40:288-293.

Prevalence of delayed puberty and low bone density in patients with epidermolysis bullosa: Insight from a large single center's experience. Wasserman, H; Dumenigo, A; Hornung, L; Augsburger, B; Marathe, K; Lucky, AW. Pediatric Dermatology. 2023; 40:100-106.

A retrospective analysis of diagnostic testing in a large North American cohort of patients with epidermolysis bullosa. Phillips, GS; Huang, A; Augsburger, BD; Kaplan, L; Peoples, K; Bruckner, AL; Khuu, P; Tang, JY; Lara-Corrales, I; Pope, E; Shwayder, T; Bayliss, S; Lucky, AW; Glick, SA. Journal of the American Academy of Dermatology. 2022; 86:1063-1071.

Pregnancy in epidermolysis bullosa: long-awaited guidelines of care. Lucky, AW; Pope, E. British Journal of Dermatology. 2022; 186:602-603.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

4.6
Overall Patient Rating